Aleksandr A. Spelkov
Papers
1
Total Citations
14
H-Index
1
About
Aleksandr A. Spelkov is a rising innovator in the field of nucleic acid nanotechnology, with a focused expertise in theranostics and RNA-targeting therapeutics. His most notable contribution is the development of a bifunctional RNA-targeting deoxyribozyme nanodevice, a pioneering platform that integrates both diagnostic and therapeutic capabilities into a single DNA-based agent. This nanodevice is designed to simultaneously report the presence of a specific RNA target via a fluorescence signal increase and cleave that target, offering high selectivity under near-physiological conditions. Such work addresses a critical need in precision medicine: the ability to detect and treat disease at the molecular level in real time. Although early in his career, Spelkov’s flagship paper has already garnered 14 citations, signaling growing interest from the drug delivery and biosensing communities. His research sits at the intersection of synthetic biology, nanomedicine, and molecular diagnostics, and his approach—leveraging DNA as both a sensor and a therapeutic agent—holds promise for advancing intelligent, responsive treatments for diseases where RNA plays a central role. Spelkov represents a new generation of researchers building multifunctional tools for the future of personalized therapy.
Research Focus
Key Achievements
Top Papers
- 1